Acular PF (Ketorolac Tromethamine Ophthalmic) - Indications and Dosage

INDICATIONS AND USAGE

ACULAR^® PF ophthalmic solution is indicated for the reduction of ocular pain and photophobia following incisional refractive surgery.

DOSAGE AND ADMINISTRATION

The recommended dose of ACULAR^® PF is one drop (0.25 mg) four times a day in the operated eye as needed for pain and photophobia for up to 3 days after incisional refractive surgery.

HOW SUPPLIED

ACULAR^® PF (ketorolac tromethamine ophthalmic solution) 0.5% Preservative-Free is available as a sterile solution supplied in clear, LDPE, single-use vials as follows:

•  ACULAR^® PF 12 Single-Use Vials 0.4 mL each: NDC 0023-9055-04

Store ACULAR^® PF at 15°C-30°C (59°F - 86°F) with protection from light.

Rx only

© 2004 Allergan
Irvine, CA 92612, U.S.A.

ACULAR^® is a registered trademark of Roche L.L.C. ACULAR^® PF is manufactured and distributed by ALLERGAN under license from its developer, Roche Palo Alto L.L.C., Palo Alto, California, U.S.A.

8718X
70899US13P